Trevarx Biomedical
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2929 Arch St Fl 3, Philadelphia, Pennsyl...Website
www.trevarx.comRevenue
<$5 MillionIndustry
About Trevarx Biomedical
Trevarx Biomedical is focused on developing innovative alpha-targeted radiopharmaceuticals that deliver targeted radioligand therapy directly to cancer DNA. Their approach aims to overcome the limitations of current therapies by targeting nuclear DNA to induce irreversible genomic damage. The company holds proprietary intellectual property covering core enabling technologies and is dedicated to improving outcomes for patients with ovarian, prostate, breast, and neuroendocrine cancers. Trevarx seeks to engage investors, physicians, and patients in their mission to revolutionize cancer treatment.Explore more
Popular SearchesTrevarx BiomedicalSIC Code 28,283NAICS Code 32,325Show moreTrevarx Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Trevarx Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Trevarx Biomedical has new funding data
Click to see if Trevarx Biomedical had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Trevarx Biomedical recently announced quarterly report
Trevarx Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Trevarx Biomedical has recently received funding, and reach out quickly before it becomes old news!
Check out if Trevarx Biomedical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Trevarx Biomedical
Product Launch: Get notified when Trevarx Biomedical launches new products
Recommended Actions
Reach out to Masked Content who joined Trevarx Biomedical as Masked Content
Find more new buyers
Trevarx Biomedical financials insights
Gather financial insights about Trevarx Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Debt
$350K
Frequently Asked Questions Regarding Trevarx Biomedical
Sign Up For FreeTo access detailed company insights
Trevarx Biomedical is focused on developing innovative alpha-targeted radiopharmaceuticals that deliver targeted radioligand therapy directly to cancer DNA. Their approach aims to overcome the limitations of current therapies by targeting nuclear DNA to induce irreversible genomic damage. The company holds proprietary intellectual property covering... Read More
